Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutrients ; 9(9)2017 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-28846640

RESUMEN

BACKGROUND: A meta-analysis was conducted to summarize the evidence from prospective cohort and case-control studies regarding the association between coffee intake and biliary tract cancer (BTC) and liver cancer risk. METHODS: Eligible studies were identified by searches of PubMed and EMBASE databases from the earliest available online indexing year to March 2017. The dose-response relationship was assessed by a restricted cubic spline model and multivariate random-effect meta-regression. A stratified and subgroup analysis by smoking status and hepatitis was performed to identify potential confounding factors. RESULTS: We identified five studies on BTC risk and 13 on liver cancer risk eligible for meta-analysis. A linear dose-response meta-analysis did not show a significant association between coffee consumption and BTC risk. However, there was evidence of inverse correlation between coffee consumption and liver cancer risk. The association was consistent throughout the various potential confounding factors explored including smoking status, hepatitis, etc. Increasing coffee consumption by one cup per day was associated with a 15% reduction in liver cancer risk (RR 0.85; 95% CI 0.82 to 0.88). CONCLUSIONS: The findings suggest that increased coffee consumption is associated with decreased risk of liver cancer, but not BTC.


Asunto(s)
Café , Medicina Basada en la Evidencia , Conducta Alimentaria , Alimentos Funcionales , Neoplasias Hepáticas/prevención & control , Neoplasias del Sistema Biliar/epidemiología , Neoplasias del Sistema Biliar/etiología , Neoplasias del Sistema Biliar/prevención & control , Estudios de Casos y Controles , Café/efectos adversos , Estudios de Cohortes , Factores de Confusión Epidemiológicos , Alimentos Funcionales/efectos adversos , Humanos , Neoplasias Hepáticas/epidemiología , Neoplasias Hepáticas/etiología , Estudios Observacionales como Asunto , Estudios Prospectivos , Reproducibilidad de los Resultados , Factores de Riesgo
2.
Molecules ; 15(10): 7125-38, 2010 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-20953157

RESUMEN

Gnagnan (Solanum indicum L.) is a spontaneous plant widely distributed in Ivory Coast. During ripening stages, Solanum indicum L. presents different colours (green, yellow and red) and is reported to contain several albeit poorly characterized antioxidant compounds. This paper describes in detail the antioxidant profile (ascorbic acid, carotenoids and polyphenols), antioxidant capacity (FRAP test and Folin-Ciocalteau assay) and the colour changes of Gnagnan berries at different ripening levels. Ascorbic acid content was similar in green and yellow berries, but significantly lower in red ones. Red berries showed a higher content of carotenoids compared to green and yellow ones. Regarding polyphenols, several phenolic acids and flavonoids were found in all berries. The content of caffeoylquinic acids, caffeic acid, flavonol glycosides and naringenin was higher in red berries, while the content of p-coumaric acid and feruloylquinic acids was similar among the three colours. The FRAP assay increased with the ripening process, whereas total polyphenols were similar among berries. Significant differences were found for the colorimetric indexes among products of different degrees of ripening. The present results show the important role of the ripening stage in increasing the antioxidant content of Gnagnan berries.


Asunto(s)
Antioxidantes/análisis , Frutas/química , Solanum , Ácido Ascórbico/análisis , Carotenoides/análisis , Color , Côte d'Ivoire , Flavonoides/análisis , Hidroxibenzoatos/análisis , Fenoles/análisis , Polifenoles , Solanum/anatomía & histología , Solanum/química , Solanum/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA